The object of the present invention are new desloratadine salts of formula
I wherein the meaning of X is an acid residue and the meaning of n is 1
or 2, and formula II wherein the meaning of X is a pK <3.5 acid
residue. The invention is related to a process for their synthesis, as
well as new anti-allergic pharmaceutical compositions containing these
salts ##STR00001##